Condition: Renovascular Hypertension · Renovascular Hypertension With Renal Failure · Heart Failure · Sponsor: University of Aarhus
The goal of this clinical trial is to document a beneficial effect of percutaneous transluminal renal angioplasty (PTRA) of atherosclerotic renal artery stenosis in high-risk patients selected according to the criteria used in the DAN-PTRA study. The main questions the trial aims to answer are if renal artery stenting compared with optimal medical treatment alone has beneficial effects on: * Blood pressure * Kidney function * Hospitalizations for heart failure
This description comes directly from the study's public registry record.
Sebastian Nielsen, MD · +45 23100484 · sebane@rm.dk
Mark Reinhard, MD, PhD · +45 40460321 · m.reinhard@dadlnet.dk
Always discuss trial participation with your own doctor first.
| Aarhus University Hospital | Aarhus N, Denmark | Recruiting |
| Rigshospitalet | Copenhagen, Denmark | Recruiting |
| Odense University Hospital | Odense C, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05834803